Table 1 Baseline demographic and clinical characteristics of study sample
From: Cognitive impairment and “invisible symptoms” are not associated with CCSVI in MS
CCSVI- | CCSVI+ | p-value | |
|---|---|---|---|
N° (%) | 34 | 27 | 0.3 |
W/M (%) | 24 (70.5) | 19 (70.3) | 1.0 |
Age (mean ± SD) | 42.3 ± 12.3 | 46.1 ± 11.1 | 0.3 |
EDSS (mean ± SD) | 3.1 ± 2.8 | 3.0 ± 2.3 | 1.0 |
Disease Duration (years; mean ± SD ) | 13 ± 9.9 | 13.7 ± 8.8 | 0.6 |
Mean Education (years; mean ± SD ) | 11.9 ± 3.9 | 12.1 ± 4.6 | 0.7 |
RR (%) | 19 (55.9) | 17 (63.0) | 0.5 |
SP (%) | 9 (26.5) | 3 (11.1) | 0.2 |
PP (%) | 2 (5.9) | 5 (18.5) | 0.2 |
CIS (%) | 4 (11.8) | 2 (7.4) | 0.7 |